|
|
||||||||
1Department of Kinesiology and 3School of Nursing, University of Wisconsin; Departments of 4Orthopedic Surgery, 5Biomedical Engineering, and 6Family Medicine, University of Wisconsin Medical School, Madison 53706; and 2Flow Cytometry Facility, University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin 53792
Submitted 6 January 2003 ; accepted in final form 30 April 2003
The purpose of this study was to determine the role of the CD11b-dependent respiratory burst in neutrophil oxidant generation and activation, interleukin-8 (IL-8) production, and myofiber damage after muscle stretch injury by using the monoclonal antibody M1/70 to block this pathway. Twelve male New Zealand White rabbits were randomly assigned to a treatment group: M1/70 (n = 6), IgG isotype control (n = 3), or saline control (n = 3). After intravenous injection of the assigned agent under gas anesthesia, a standardized single-stretch injury was created in the right tibialis anterior, whereas the left tibialis anterior underwent a sham surgery. Blood-borne neutrophil oxidant generation and CD11b receptor density and plasma IL-8 levels were measured pre- and 24 h postinjury. Damage was assessed histologically at the hematoma site by counting torn myofibers. M1/70 group demonstrated decreased blood-borne neutrophil oxidant generation (P < 0.05) and CD11b receptor density (P < 0.05), an increase in plasma IL-8 concentration (P < 0.01), and less torn myofibers (P < 0.01) compared with IgG isotype or saline control groups. These data indicate that 1) CD11b-dependent respiratory burst is a major source of oxidants produced by the neutrophil, and that treatment with M1/70 2) attenuates neutrophil activation status, 3) increases plasma IL-8 concentration, and 4) minimizes myofiber damage 24 h postmuscle stretch injury.
eccentric contraction; chemokine; respiratory burst; CD11b
This article has been cited by other articles:
![]() |
J. W Orchard, T. M Best, H.-W. Mueller-Wohlfahrt, G. Hunter, B. H Hamilton, N. Webborn, R. Jaques, D. Kenneally, R. Budgett, N. Phillips, et al. The early management of muscle strains in the elite athlete: best practice in a world with a limited evidence basis Br. J. Sports Med., March 1, 2008; 42(3): 158 - 159. [Full Text] [PDF] |
||||
![]() |
E. P. Rader, W. Song, H. Van Remmen, A. Richardson, and J. A. Faulkner Raising the antioxidant levels within mouse muscle fibres does not affect contraction-induced injury Exp Physiol, July 1, 2006; 91(4): 781 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Vignaud, J Cebrian, I Martelly, J.-P Caruelle, and A Ferry Effect of anti-inflammatory and antioxidant drugs on the long-term repair of severely injured mouse skeletal muscle Exp Physiol, July 1, 2005; 90(4): 487 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. H. Jarvinen, T. L. N. Jarvinen, M. Kaariainen, H. Kalimo, and M. Jarvinen Muscle Injuries: Biology and Treatment Am. J. Sports Med., May 1, 2005; 33(5): 745 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Tidball Inflammatory processes in muscle injury and repair Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R345 - R353. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. X Pizza, J. M Peterson, J. H Baas, and T. J Koh Neutrophils contribute to muscle injury and impair its resolution after lengthening contractions in mice J. Physiol., February 1, 2005; 562(3): 899 - 913. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |